Press release
Gastroretentive Drug Delivery Systems Outsourcing Market Expands as Bioavailability Improvements Drive Innovation
Gastroretentive Drug Delivery Systems Outsourcing Market
According to the latest research by InsightAce Analytic, the Global Gastroretentive Drug Delivery Systems Outsourcing Market is valued at US$ 1.26 Bn in 2022, and it is expected to reach US$ 2.32 Bn by 2031, with a CAGR of 7.22% during a forecast period of 2023-2031.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2154
The gastroretentive drug delivery system (GRDDS) represents an innovative approach to pharmaceutical administration, offering significant advantages through the prolonged retention of therapeutic agents within the stomach. This extended gastric residence time has been shown to enhance drug bioavailability, thereby contributing to the system's growing adoption and supporting a favorable market outlook. The rising global prevalence of chronic diseases is further accelerating the demand for outsourced GRDDS solutions. Advances in formulation technologies are expected to unlock new opportunities for market development. In particular, progress in polymer science, controlled-release methodologies, and techniques to improve bioavailability has facilitated the creation of more sophisticated and customized GRDDS solutions. Additionally, the increasing incidence of gastrointestinal conditions, such as peptic and gastric ulcers, is anticipated to further drive market growth in the coming years.
List of Prominent Players in the Gastroretentive Drug Delivery Systems Outsourcing Market:
• Catalent
• Lonza
• Evonik
• Colorcon
• Quotient Sciences
• Aptar Pharma
• Aenova Group
• Evotec
• Vectura Group Ltd.
• Ashland
• Calera Corporation
• Others
Market Dynamics:
Drivers-
Gastroretentive drug delivery systems (GRDDS) provide sustained drug release and enable localized drug administration within the stomach and small intestine. The rising incidence of gastrointestinal disorders affecting these regions is expected to significantly drive market demand. Furthermore, the growing global burden of disease, coupled with the proven efficacy of GRDDS in treating gastric conditions such as peptic and gastric ulcers, serves as a key driver of market expansion. By extending the drug's residence time in the stomach, these systems facilitate increased drug concentration at the targeted site of action, thereby enhancing bioavailability and reducing the required dosage. This results in improved therapeutic outcomes and supports overall market growth. Additionally, the increasing prevalence of Helicobacter pylori infections-linked to conditions such as gastritis, gastroduodenal ulcers, and gastric cancer-is anticipated to further stimulate demand for GRDDS solutions.
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-02
Challenges:
The gastroretentive drug delivery systems outsourcing market faces several challenges that may hinder growth. Stringent regulatory requirements and industry compliance standards represent a substantial hurdle, as adherence can be both time-intensive and costly. The market is also characterized by intense competition, with numerous outsourcing firms competing for limited contracts, potentially affecting profit margins and contract acquisition. Additionally, the need for outsourcing partners to possess adequate production capacity and scalability becomes critical, particularly during periods of accelerated market demand. Intellectual property protection remains another major concern, as companies must carefully manage the exchange of proprietary information with third-party vendors while ensuring data confidentiality and security.
Regional Trends:
North America is anticipated to hold a dominant share of the gastroretentive drug delivery systems outsourcing market, driven by a rising prevalence of gastric cancers, increased investment in research and development, and strategic initiatives by key industry players, particularly in the United States. The region's strong adoption of advanced drug delivery technologies and targeted treatment protocols further supports market growth. In addition, Europe maintains a significant market share, bolstered by a high incidence of cancer, a mature pharmaceutical industry, and proactive engagement from major market participants. The presence of a favorable regulatory landscape in Europe also contributes to the region's growth trajectory.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2154
Recent Developments:
• In August 2022, Catalent revealed its intention to purchase Metrics Contract Services for USD 475 million. This strategic move aims to enhance Catalent's promising capabilities and increase its oral development and manufacturing capacity.
Segmentation of Gastroretentive Drug Delivery Systems Outsourcing Market-
By Dosage Form
• Tablets
• Liquid
• Microspheres
• Capsule
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa
Read Overview Report- https://www.insightaceanalytic.com/report/gastroretentive-drug-delivery-systems-outsourcing-market/2154
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gastroretentive Drug Delivery Systems Outsourcing Market Expands as Bioavailability Improvements Drive Innovation here
News-ID: 3993860 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Fuel Cell Commercial Vehicle Market Exclusive Report on Current Trends and Futur …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Fuel Cell Commercial Vehicle Market Size, Share & Trends Analysis Report By Vehicle (Light commercial vehicles, Medium commercial vehicles, Heavy commercial vehicles), Fuel Cell Technology (Proton exchange membrane, Alkaline fuel cells, Solid oxide fuel cells), Range (Short-range, Medium-range, Long-range), End User (Public transit, Construction and mining, Logistics & transportation, Others)- Market Outlook And Industry Analysis…
Zero Emission Vehicle Market is on an Upward Growth Curve
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Zero Emission Vehicle Market"-, By Vehicle Class (Passenger Cars, Commercial Vehicles, Two-Wheeler), By Drive (Front Wheel, Rear Wheel, All-Wheel), By Top Speed (Less than 100 Mph, 100 to 125 Mph, more than 125 Mph), By Vehicle Type (Battery Electric Vehicles (BEVs), Fuel Cell Electric Vehicles (FCEVs)), and Global Forecasts, 2024-2031 And Segment Revenue and Forecast To…
Hydrogen Vehicles Market Report- Expansive Coverage on the Profit Sources
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Hydrogen Vehicles Market"-, By Technology (PAFC (Phosphoric Acid Fuel Cell), DMFC (Direct Methanol Fuel Cell), and PEMFC (Proton Exchange Membrane Fuel Cell)), By Fuel Capacity (Up to 75 kW, 76 to 100 kW, 101 to 150 kW, Above 150 kW), By Vehicle Category (Passenger, Commercial) Industry Trends, and Global Forecasts, 2024-2031 And Segment Revenue and Forecast…
Autonomous Mobility Ecosystem Market Future Trends and Scope Analysis Report
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Autonomous Mobility Ecosystem Market"-, By Type (People Move Autonomously, Cargo Moves Autonomously), By Application (Civil, Defense, Transportation and Logistics, Others), Industry Trends, and Global Forecasts, 2024-2031 And Segment Revenue and Forecast To 2031."
The Autonomous Mobility Ecosystem Market is estimated to exhibit a CAGR of 34.8% during the forecast period.
Request For Free Sample Pages:
https://www.insightaceanalytic.com/request-sample/2641…
More Releases for Gastroretentive
Rising Prevalence Of Gastrointestinal Disorders Drives Growth In Gastroretentive …
The Gastroretentive Drug Delivery Systems Outsourcing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Gastroretentive Drug Delivery Systems Outsourcing Market Size and Its Estimated Growth Rate?
The gastroretentive drug delivery systems outsourcing market has shown strong growth in recent years. It will…
Top Factor Driving Gastroretentive Drug Delivery Systems Outsourcing Market Grow …
Which drivers are expected to have the greatest impact on the over the gastroretentive drug delivery systems outsourcing market's growth?
The increasing incidence of gastrointestinal disorders is expected to boost the growth of the gastroretentive drug delivery systems outsourcing market. Gastrointestinal disorders are on the rise due to factors like aging populations, antibiotic use, changes, and obesity. Outsourcing gastroretentive drug delivery systems allows pharmaceutical companies to address the growing demand…
Rising Prevalence Of Gastrointestinal Disorders Drives Growth In Gastroretentive …
How Will the Gastroretentive Drug Delivery Systems Outsourcing Market Grow, and What Is the Projected Market Size?
In recent times, the market size for outsourcing of gastroretentive drug delivery systems has expanded significantly. Projected growth estimates indicate an increase from $1.39 billion in 2024 to $1.5 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.3%. Several factors have contributed to this growth during the historic period, including a…
Gastroretentive Drug Delivery Systems Market Will Exhibit an Impressive Expansio …
The global gastroretentive drug delivery systems market is anticipated to grow at a CAGR of around 6.3% during the forecast period. The rising prevalence of functional gastrointestinal disorders (FGIDs), and gastric disorders majorly among the geriatric population globally is the major factor augmenting the growth of the gastroretentive drug delivery systems. The aged population is more susceptible to long-standing conditions such as dyspepsia, irritable bowel syndrome, inflammatory bowel disease (Crohn's…
Gastroretentive Drug Delivery Systems Market Outlook 2029: Presents Market Insig …
The global gastroretentive drug delivery systems market is anticipated to grow at a CAGR of around 6.3% during the forecast period. The rising prevalence of functional gastrointestinal disorders (FGIDs), and gastric disorders majorly among the geriatric population globally is the major factor augmenting the growth of the gastroretentive drug delivery systems. The aged population is more susceptible to long-standing conditions such as dyspepsia, irritable bowel syndrome, inflammatory bowel disease (Crohn's disease and…
Gastroretentive Drug Delivery Systems Market to Witness Robust Expansion by 2029
The global gastroretentive drug delivery systems market is anticipated to grow at a CAGR of around 6.3% during the forecast period. The rising prevalence of functional gastrointestinal disorders (FGIDs), and gastric disorders majorly among the geriatric population globally is the major factor augmenting the growth of the gastroretentive drug delivery systems. The aged population is more susceptible to long-standing conditions such as dyspepsia, irritable bowel syndrome, inflammatory bowel disease (Crohn's…
